Other Events ·
VivoSim Labs, Inc. received a Nasdaq delisting notice due to failing to meet the $2.5 million minimum stockholders'…
VIVSVivoSim Labs, Inc.
VivoSim Labs, Inc. received a Nasdaq delisting notice due to failing to meet the $2.5 million minimum stockholders' equity requirement. The company has until September 3, 2026, to submit a compliance plan, though recent capital raises and a $5.0 million milestone payment from Eli Lilly and Company have brought stockholders' equity above the $2.5 million threshold. VivoSim Labs, Inc. is a biotechnology company focused on developing FXR assets.